ADIPOQ and obesity disorder: In other words, despite the elevated serum levels of adiponectin, which hypothetically may trigger its protective effects, adiponectin sequestration in tissues and subsequent signal transduction through its receptors are impaired, particularly among individuals with obesity (Barbalho et al., 2023).